Home・Akcijų sąrašas・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

575.5 -0.21

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

562.67

Max

577.21

Pagrindiniai rodikliai
By Trading Economics
Pajamos	85M 1.7B
Pardavimai	989M 12B
P/E Sektoriaus vid.	30.575 64.641
Pelnas, tenkantis vienai akcijai	6.03
Dividendų pajamingumas	0.15
Pelno marža	14.516
Darbuotojai	125,000
EBITDA	262M 2.6B

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+6.98% upside

Dividendai
By Acuity
Dividendų pajamingumas Sektoriaus vid.	0.15% 2.31%
Kitas uždarbis	2026-10-21
Kitas dividendų mokėjimo data	2026-10-15
Kita Ex Dividend data	2026-09-15

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	17B 213B
Ankstesnė atidarymo kaina	575.71
Ankstesnė uždarymo kaina	575.5

Naujienos nuotaikos

By Acuity

23%

77%

66 / 340 reitingas Healthcare

Thermo Fisher Scientific Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-31 22:41; UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

2026-07-30 19:09; UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

2026-07-29 23:16; UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

2026-07-28 18:06; UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

2026-07-27 18:01; UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

2026-07-24 19:23; UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

2026-07-23 23:01; UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

2026-07-22 23:02; UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

2026-07-21 22:01; UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

2026-07-20 19:46; UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Akcijų palyginimas

Kainos pokytis

Thermo Fisher Scientific Inc Prognozė

Kainos tikslas

By TipRanks

6.98% į viršų

12 mėnesių prognozė

Vidutinis 614.41 USD 6.98%

Aukščiausias 690 USD

Žemiausias 520 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Thermo Fisher Scientific Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

19 ratings

Pirkti

Laikyti

Parduoti

Remiantis 19 analitikų, pateikusių Thermo Fisher Scientific Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

66 / 340 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar